Companies with a Health score of at least 4, ordered by Health score.
Spectral Medical Inc. focuses on the development and commercialization of treatment for septic shock in North America.
IBEX Technologies Inc., through its subsidiaries, manufactures and markets enzymes for biomedical use in Canada, the United States, the United Kingdom, and internationally.
Medicenna Therapeutics Corp., a clinical stage immunotherapy company, develops and commercializes Empowered Cytokines (EC) and Superkines for the treatment of cancer.
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing pharmaceutical therapies for treating oncology and endocrinology.
Cybin Inc., a life sciences company, focuses on the psychedelic drug development to treat various psychiatric and neurological conditions.
BioSyent Inc., a specialty pharmaceutical company, through its subsidiaries, sources, acquires or in-licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in the United States.
InnoCan Pharma Corporation focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in Israel.
Mydecine Innovations Group Inc. operates as a biopharma and life sciences company which focuses on research, development, acceptance, and commercialization of alternative nature-sourced medicine for treating mental health problems.
Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada.
Antibe Therapeutics Inc., a pharmaceutical development company, originates, develops, and out-licenses patent novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally.
XORTX Therapeutics Inc., a bio-pharmaceutical company, focuses on the development and commercialization of therapies to treat progressive kidney diseases worldwide.
Nova Mentis Life Science Corp., through its subsidiaries, focuses on developing medicinal psychedelics for neuroinflammatory conditions with a focus on autism spectrum disorder.
48North Cannabis Corp. operates as a cannabis company in the health and wellness market in Canada.
PharmaTher Inc., pharmaceutical company, engages in repurposing psychedelic-derived drugs using artificial intelligence platform.
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of chronic cough and other hypersensitization disorders.
Cronos Group Inc. operates as a cannabinoid company in the United States and internationally.
Heritage Cannabis Holdings Corp., through its subsidiaries, focuses on becoming a vertically integrated cannabis provider in Canada.
Weekend Unlimited Industries Inc. operates in the regulated cannabis industry in the United States and Canada.
Medicure Inc., a pharmaceutical company, engages in the research, development, and commercialization of therapies for the cardiovascular market in the United States.
Terrace Global Inc. engages in the development and acquisition of international cannabis assets.
Innovotech Inc. provides solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada, the United States, and internationally.
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer.
WPD Pharmaceuticals Inc. engages in the research and development of medicinal products in the fields of oncology and infectious disease.
